☆ 4.7 Article

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

Matthijs P. Raadsen et al.

Summary: The study found that neutralizing IFN-alpha 2 Abs were present in COVID-19 patients, with proportions increasing with disease severity and age. Patients with IFN-alpha 2 Abs in the acute stage of the disease experienced delayed viral clearance. Convalescent plasma donors with anti-IFN-alpha 2 Abs did not show neutralizing effects in the conditions tested.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital

Angelique Chauvineau-Grenier et al.

Summary: Recent studies have found that pre-existing autoantibodies neutralizing type I interferons (IFNs) are present in at least 15% of patients with critical COVID-19 pneumonia, increasing the risk of mortality. This highlights the importance of type I IFN immunity in defense against SARS-CoV-2 infection and the usefulness of detecting autoantibodies for patient management.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Germinal centre-driven maturation of B cell response to mRNA vaccination

Wooseob Kim et al.

Summary: SARS-CoV-2 mRNA vaccination induces a persistent germinal center reaction in humans, resulting in affinity-matured long-term antibody responses that potently neutralize the virus.

NATURE (2022)

Add to Collection

Review Multidisciplinary Sciences

Human genetic and immunological determinants of critical COVID-19 pneumonia

Qian Zhang et al.

Summary: SARS-CoV-2 infection is generally mild, but in around 10% of cases, it can lead to severe pneumonia and potentially death. Genetic factors, such as inborn errors of type I interferons, and pre-existing auto-antibodies can increase the risk of critical illness. The production of type I interferons is essential for host defense against the virus.

NATURE (2022)

Add to Collection

Article Medicine, General & Internal

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

E. B. Walter et al.

Summary: A regimen of two 10-mu g doses of BNT162b2 administered 21 days apart was found to be safe, immunogenic, and efficacious in children aged 5 to 11 years.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Immunology

Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant

Aurelien Sokal et al.

Summary: The Omicron variant of SARS-CoV-2 is able to escape neutralization by antibodies elicited by vaccines and previous infection. However, the memory B cells (MBCs) generated by mRNA vaccines can still recognize and neutralize the Omicron variant to some extent, providing a certain level of protection for vaccinated individuals.

IMMUNITY (2022)

Add to Collection

Article Immunology

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes

Paul Bastard et al.

Summary: Autosomal recessive IFNAR1 deficiency is a rare inborn error of immunity that leads to susceptibility to viral diseases. This study reports the presence of this deficiency in seven children of western Polynesian ancestry, highlighting its higher prevalence in this population.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Immunology

IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

Siri Tahtinen et al.

Summary: Lipid-formulated RNA vaccines can cause systemic inflammatory responses in humans, which were not predicted in preclinical studies. The IL-1 pathway plays a key role in triggering vaccine-induced inflammation, but this effect is dampened in mice.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine

Chunfeng Li et al.

Summary: The BNT162b2 mRNA vaccine stimulates potent antibody and antigen-specific T cell responses, as well as enhanced innate responses after secondary immunization. Circulating IFN-gamma is mainly produced by natural killer cells and CD8(+) T cells in the draining lymph nodes. The CD8(+) T cell response is dependent on type I interferon-dependent MDA5 signaling.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

Tessa Mollie Campbell et al.

Summary: IRF7-deficient individuals are prone to viral infections of the respiratory tract but are otherwise healthy, potentially due to residual IFN-beta and compensatory adaptive immunity.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: A study quantified the global impact of the first year of COVID-19 vaccination programs, finding that the vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact, reinforcing the need for global vaccine equity and coverage.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread

Jean-Laurent Casanova et al.

Summary: The vast individual clinical variability during infections has long been a puzzle, but studying inborn errors and mechanisms of rare infections has helped identify common genetic or autoimmune determinants of related common infections like tuberculosis and COVID-19. Genetic factors or autoimmune determinants may contribute to the severity of infections, and this rare-to-common genetic and mechanistic approach may be informative for infectious disease research.

CELL (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: The study estimated that COVID-19 vaccination has prevented millions of deaths globally between December 8, 2020, and December 8, 2021. Achieving the vaccination coverage targets set by COVAX and WHO could have prevented even more deaths. However, limited access to vaccines in low-income countries has hindered the impact, highlighting the importance of global vaccine equity.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Iivo Hetemaki et al.

Summary: The study revealed that higher titers of neutralizing anti-IFN alpha 4 antibodies in APS-1 patients are associated with a higher and earlier incidence of VZV reactivation, leading to more severe clinical sequelae of herpetic infections. These results suggest that blocking the type I interferon pathway in APS-1 patients results in a clinically significant immune deficiency, emphasizing the importance of considering susceptibility to herpesviruses when treating APS-1 patients.

CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis

Christina Krienke et al.

Summary: The study demonstrates the potential use of modified m1 Psi mRNA in the treatment of multiple sclerosis, showing its ability to suppress the disease, promote the development of T-reg cell populations, and enhance bystander immunosuppression.

SCIENCE (2021)

Add to Collection

Article Immunology

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad-Gabriel Alameh et al.

Summary: Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have intrinsic adjuvant activity that enhances durable and protective antibody responses. Compared to the widely used MF59-like adjuvant AddaVax, this LNP formulation outperforms and relies on specific components and cytokine induction for its adjuvant activity.

IMMUNITY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Alice Cho et al.

Summary: Infection with SARS-CoV-2 leads to evolving B cell responses over at least a year, while vaccination with mRNA vaccines results in high plasma neutralizing activity against various variants. Memory B cells from vaccinated individuals show increased neutralizing activity between prime and boost, but do not exhibit further expansion in potency or breadth.

NATURE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

In Gratitude for mRNA Vaccines

Elizabeth G. Phimister

Summary: The production of mRNA vaccines against SARS-CoV-2 set a record in 11 months, but the preclinical research behind it spanned decades and faced challenges due to lack of funding. The 2021 Lasker-DeBakey Clinical Medical Research Award was given to Drs. Drew Weissman and Katalin Kariko, pioneer researchers of modified RNA.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

Fanny Onodi et al.

Summary: Studies have shown that human pDCs can be efficiently activated by SARS-CoV-2 particles and may contribute to type I IFN-dependent immunity against SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Rishi R. Goel et al.

Summary: This study found that immune memory to SARS-CoV-2 and its variants remains robust for at least 6 months after mRNA vaccination, with antibodies declining but still detectable in most individuals. mRNA vaccines also induced functional memory B cells and antigen-specific T cells, with recall responses primarily increasing antibody levels in individuals with preexisting immunity.

SCIENCE (2021)

Add to Collection

Review Multidisciplinary Sciences

Mechanisms of viral inflammation and disease in humans

Jean-Laurent Casanova et al.

Summary: Disease and inflammation are rare outcomes of viral infection in humans, often due to a failure in cell-intrinsic and leukocytic immunity to viruses. Inflammation indicates the efforts of newly recruited and activated leukocytes to resolve infection. Genetic studies can help clarify the underlying causes of inflammation and disease in viral infections.

SCIENCE (2021)

Add to Collection

Article Cell Biology

mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent

Andaleeb Sajid et al.

Summary: The study showed that vaccination with 19ISP mRNA can enhance host recognition of tick bites, reduce tick engorgement, and prevent B. burgdorferi infection. Immunization with 19ISP also hindered the transmission of the pathogen in vaccinated guinea pigs.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Letter Critical Care Medicine

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients

Rutger Koning et al.

INTENSIVE CARE MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Linde Schoenmaker et al.

Summary: The current mRNA-lipid nanoparticle COVID-19 vaccines require storage at low temperatures due to instability. Improving mRNA nucleotide composition, understanding the impact of mRNA environment within LNPs, and exploring drying techniques can enhance vaccine stability.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Letter Immunology

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

Sara E. Vazquez et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Jesus Troya et al.

Summary: In severe cases of COVID-19 pneumonia, approximately 10.6% of patients were found to have autoantibodies neutralizing type I IFN, which correlated with increased C-reactive protein levels and decreased lymphocyte counts, possibly increasing the risk of death. Subcutaneous IFN-beta treatment did not seem to improve clinical outcomes.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses

Jennifer Hicks et al.

Summary: Researchers evaluated the presence of serum antibodies of people worldwide experiencing the pandemic using recombinant proteins from the viral genome. They found potential cross-reactivity of SARS-CoV-2 antibodies with other coronaviruses, with the strongest recognition between SARS-CoV-2 and SARS/MERS-CoV antibodies. Further analysis of cross-reactivity could lead to intelligently designed pan-coronavirus therapeutics or vaccines.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Paul Bastard et al.

Summary: Patients with biallelic loss-of-function variants of AIRE, suffering from APS-1, produce autoantibodies that neutralize most type I interferons, leading to a significantly increased risk of life-threatening COVID-19 pneumonia. Research has shown that in APS-1 patients with these neutralizing autoantibodies, 86% developed COVID-19 pneumonia.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike

Pei Tong et al.

Summary: Memory B cell reserves can produce protective antibodies against SARS-CoV-2, but the impact on variants is unclear. Studying antibodies from convalescent individuals revealed seven major antibody competition groups, important for neutralizing the virus.

CELL (2021)

Add to Collection

Article Immunology

mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants

Aurelien Sokal et al.

Summary: This study examined the MBC responses in recovered and naive individuals after mRNA vaccination against SARS-CoV-2, finding that the MBC pool in recovered individuals expanded selectively, matured further, and had potent neutralizers against VOCs. Naive individuals displayed weaker neutralizing serum responses, but a significant portion of their RBD-specific MBCs showed high affinity to multiple VOCs, suggesting potential efficient response to VOCs in naive vaccinees.

IMMUNITY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Jackson S. Turner et al.

Summary: SARS-CoV-2 mRNA vaccines induce a persistent germinal centre B cell response in humans, leading to the generation of robust humoral immunity, especially more significant in individuals previously infected with the virus.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

Kashif Ali et al.

Summary: The study demonstrates that the mRNA-1273 vaccine has good safety profile in adolescents aged 12 to 17 years, with immune response similar to that in young adults. It also proves the efficacy of the vaccine in preventing Covid-19 in this age group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

S. J. Thomas et al.

Summary: BNT162b2 vaccine remains highly effective and safe over the course of 6 months post-vaccination, with efficacy rates ranging from 86% to 100% across different demographics and risk factors for Covid-19. The vaccine also shows a high efficacy against severe disease, with particularly promising results observed in South Africa against the B.1.351 variant.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants

Amarendra Pegu et al.

Summary: The study assessed the impact of SARS-CoV-2 variants on antibody responses induced by the mRNA vaccine over 7 months, showing that most individuals maintained binding and functional antibodies against variants, with B.1.351 having the lowest antibody recognition.

SCIENCE (2021)

Add to Collection

Article Cell Biology

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

Monique G. P. van der Wijst et al.

Summary: Autoantibodies against type I interferons have been identified in some patients with critical COVID-19, with higher prevalence in severe cases. The longitudinal dynamics and functional effects of these antibodies on circulating leukocytes remain unclear.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Cristina Bergamaschi et al.

Summary: Early responses to vaccination play a crucial role in shaping both humoral and cellular protective immunity. This study characterizes cytokine and chemokine responses after the first and second dose of the BNT162b2 mRNA vaccine, highlighting the potential for biomarkers like IL-15 and IFN-gamma in predicting humoral immunity development. In previously COVID-19-infected individuals, a single vaccination can trigger strong cytokine induction and antibody responses similar to those seen in naive individuals upon booster vaccination, with implications for future public health recommendations.

CELL REPORTS (2021)

Add to Collection

Article Immunology

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

Paul Bastard et al.

Summary: Autoantibodies neutralizing interferons are present in a significant percentage of critical COVID-19 patients, especially in older individuals, and their prevalence increases with age.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Immunology

X-linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life-threatening COVID-19

Takaki Asano et al.

Summary: A study revealed that rare X-linked TLR7 variants were found in 16 unrelated male individuals with critical COVID-19 pneumonia out of a cohort of 1202 male patients. No such variants were detected in 331 asymptomatic or mildly infected male individuals.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1

Christian Meisel et al.

Summary: This study found that patients with APS-1 and preexisting neutralizing autoantibodies against IFN-alpha and IFN-omega developed only mild symptoms of COVID-19 after contracting SARS-CoV-2, without progressing to severe cases. These patients were mostly female and under the age of 26.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Immunology

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients

David Goncalves et al.

Summary: The study found that some critically ill COVID-19 patients have autoantibodies against IFN-I, which may impair the immune response. However, patients with neutralizing anti-IFN-alpha(2) autoantibodies showed no significant differences in clinical characteristics or outcomes.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Add to Collection

Letter Endocrinology & Metabolism

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

G. Beccuti et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Impact of mRNA chemistry and manufacturing process on innate immune activation

Jennifer Nelson et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Add to Collection

Article Cell Biology

Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal

Nicole A. de Weerd et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Add to Collection

Review Immunology

RIG-I-like receptors: their regulation and roles in RNA sensing

Jan Rehwinkel et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Type I interferon induces CXCL13 to support ectopic germinal center formation

Alice E. Denton et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Add to Collection

Article Immunology

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines

Nicholas Hernandez et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Add to Collection

Review Medicine, General & Internal

Autoimmune Polyendocrine Syndromes

Eystein S. Husebye et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

Steffen Meyer et al.

CELL (2016)

Add to Collection

Review Immunology

Discriminating self from non-self in nucleic acid sensing

Martin Schlee et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Add to Collection

Article Biochemical Research Methods

Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data

Namita T. Gupta et al.

BIOINFORMATICS (2015)

Add to Collection

Article Multidisciplinary Sciences

Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency

Michael J. Ciancanelli et al.

SCIENCE (2015)

Add to Collection

Review Immunology

Interferons and viruses: an evolutionary arms race of molecular interactions

Hans-Heinrich Hoffmann et al.

TRENDS IN IMMUNOLOGY (2015)

Add to Collection

Review Biotechnology & Applied Microbiology

mRNA-based therapeutics - developing a new class of drugs

Ugur Sahin et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Add to Collection

Review Immunology

Toll-like receptor signaling pathways

Takumi Kawasaki et al.

FRONTIERS IN IMMUNOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Katalin Kariko et al.

NUCLEIC ACIDS RESEARCH (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Bart R. Anderson et al.

NUCLEIC ACIDS RESEARCH (2010)

Add to Collection

Article Biochemical Research Methods

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

Thomas Tiller et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2008)

Add to Collection

Article Biotechnology & Applied Microbiology

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Kariko et al.

MOLECULAR THERAPY (2008)

Add to Collection

Article Immunology

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-λ) genes

Pamela I. Osterlund et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Immunology

Type IIFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus

Jiangao Zhu et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Immunology

Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA

K Karikó et al.

IMMUNITY (2005)

Add to Collection

Article Biochemistry & Molecular Biology

mRNA is an endogenous ligand for Toll-like receptor 3

K Karikó et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.